How Gender-Affirming Treatment Affects Erythrocytosis How Gender-Affirming Treatment Affects Erythrocytosis

Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news